Cidara’s Non-Vaccine Flu Preventive Offers Respite From Vaccine Conflicts

Non-vaccine approaches to influenza prevention like Cidara's CD388 could be a safe harbor during US vaccine policy upheaval. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Breakthrough Designations

More from Vaccines